世界のポリクローナル抗体市場は、2022年に約10億5,424万米ドルと評価され、予測期間の2023年から2030年には5.70%以上の成長率で成長すると予測されています。ポリクローナル抗体は、抗原の導入に反応する動物（一般的には哺乳類）の免疫反応に由来する抗体の一種です。ポリクローナル抗体は、異なるB細胞によって産生される抗体の不均一な混合物であり、それぞれが抗原上の異なるエピトープを認識します。動物でポリクローナル抗体を産生するには、同じ抗原を繰り返し投与する必要があります。ポリクローナル抗体は、多くのB細胞系譜によって作られた抗体の集合体です。これらの抗体は、特定の抗原に結合し、様々な抗原エピトープを認識する免疫グロブリン分子のグループです。ウサギ、マウス、ヤギなどの哺乳動物にウイルスを接種すると、抗体が頻繁に産生されます。哺乳動物が抗原を受け取った後、B細胞はその抗原専用の免疫グロブリンG（IgG）を産生します。市場の成長は、医療産業の進歩、神経生物学と幹細胞研究の成長、ハイテク製品の入手しやすさの結果として拡大すると予想されます。
さらに、感染症や慢性疾患の増加、がん罹患率の上昇が世界のポリクローナル抗体市場を押し上げると予測されています。世界がん研究基金インターナショナル（World Cancer Research Fund International）は、2020年には世界で約1,810万人のがん患者が新たに発生し、そのうち930万人が男性、880万人が女性であると推定しています。さらに、大手製薬企業やバイオテクノロジー企業も世界的に研究開発努力を拡大し、市場にさまざまな成長展望をもたらすと予想されます。さらに、世界のポリクローナル抗体市場の業界リーダーは、提携、M&A、共同研究など、さまざまな戦略を採用しており、業界には複数の成長機会がもたらされる可能性が高いです。しかし、ポリクローナル抗体市場は、2023年から2030年の予測期間を通じて、研究用抗体の高価格や、一部の抗体の純度や濃度レベルの低さなどの課題に直面すると予想されます。
世界のポリクローナル抗体市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、トップ企業が集中しており、研究開発が進んでいることから、2022年の市場を独占しました。アジア太平洋は、2023年から2030年の予測期間中に最も速いCAGRで成長すると予想されます。がんやその他の疾患の発生率の上昇、インド、中国、韓国などの国における医療インフラの進歩、個別化医療に対する需要の増加、同地域における治療用抗体に対する需要の高まりなどの要因が挙げられます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Polyclonal Antibodies Market, by region, 2020-2030 (USD Million)
1.2.2. Polyclonal Antibodies Market, by Product, 2020-2030 (USD Million)
1.2.3. Polyclonal Antibodies Market, by Application, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Polyclonal Antibodies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Polyclonal Antibodies Market Dynamics
3.1. Polyclonal Antibodies Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing healthcare industry
3.1.1.2. Increased neurobiology and stem cell research
3.1.1.3. Increase in the incidences of infectious and chronic diseases
3.1.2. Market Challenges
3.1.2.1. High cost of polyclonal antibodies
3.1.2.2. Low purity and concentration levels of some of the antibodies
3.1.3. Market Opportunities
3.1.3.1. Growing Research and Development
3.1.3.2. Surging initiatives by the key market players
Chapter 4. Global Polyclonal Antibodies Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Polyclonal Antibodies Market, by Product
5.1. Market Snapshot
5.2. Global Polyclonal Antibodies Market by Product, Performance - Potential Analysis
5.3. Global Polyclonal Antibodies Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Polyclonal Antibodies Market, Sub Segment Analysis
5.4.1. Primary Antibody
5.4.2. Secondary Antibody
Chapter 6. Global Polyclonal Antibodies Market, by Application
6.1. Market Snapshot
6.2. Global Polyclonal Antibodies Market by Application, Performance - Potential Analysis
6.3. Global Polyclonal Antibodies Market Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Polyclonal Antibodies Market, Sub Segment Analysis
6.4.1. Academic Research
6.4.2. Commercial
Chapter 7. Global Polyclonal Antibodies Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Polyclonal Antibodies Market, Regional Market Snapshot
7.4. North America Polyclonal Antibodies Market
7.4.1. U.S. Polyclonal Antibodies Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Polyclonal Antibodies Market
7.5. Europe Polyclonal Antibodies Market Snapshot
7.5.1. U.K. Polyclonal Antibodies Market
7.5.2. Germany Polyclonal Antibodies Market
7.5.3. France Polyclonal Antibodies Market
7.5.4. Spain Polyclonal Antibodies Market
7.5.5. Italy Polyclonal Antibodies Market
7.5.6. Rest of Europe Polyclonal Antibodies Market
7.6. Asia-Pacific Polyclonal Antibodies Market Snapshot
7.6.1. China Polyclonal Antibodies Market
7.6.2. India Polyclonal Antibodies Market
7.6.3. Japan Polyclonal Antibodies Market
7.6.4. Australia Polyclonal Antibodies Market
7.6.5. South Korea Polyclonal Antibodies Market
7.6.6. Rest of Asia Pacific Polyclonal Antibodies Market
7.7. Latin America Polyclonal Antibodies Market Snapshot
7.7.1. Brazil Polyclonal Antibodies Market
7.7.2. Mexico Polyclonal Antibodies Market
7.8. Middle East & Africa Polyclonal Antibodies Market
7.8.1. Saudi Arabia Polyclonal Antibodies Market
7.8.2. South Africa Polyclonal Antibodies Market
7.8.3. Rest of Middle East & Africa Polyclonal Antibodies Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Thermo Fisher Scientific Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Merck KGaA
8.3.3. Abcam plc
8.3.4. Bio-Rad Laboratories Inc.
8.3.5. Cell Signaling Technology Inc.
8.3.6. F. Hoffmann-La Roche Ltd.
8.3.7. Danaher Corporation
8.3.8. Agilent Technologies
8.3.9. PerkinElmer Inc.
8.3.10. BioLegend, Inc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Polyclonal Antibodies Market, report scope
TABLE 2. Global Polyclonal Antibodies Market estimates & forecasts by region 2020-2030 (USD Million)
TABLE 3. Global Polyclonal Antibodies Market estimates & forecasts by Product 2020-2030 (USD Million)
TABLE 4. Global Polyclonal Antibodies Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 5. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 6. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. U.S. Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 17. U.S. Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. Canada Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. Canada Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. UK Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. UK Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. Germany Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. Germany Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. France Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. France Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. Italy Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. Italy Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Spain Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Spain Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. RoE Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. RoE Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. China Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. China Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. India Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. India Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. Japan Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. Japan Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. South Korea Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. South Korea Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. Australia Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. Australia Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. RoAPAC Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. RoAPAC Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. Brazil Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. Brazil Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Mexico Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Mexico Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. RoLA Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. RoLA Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. Saudi Arabia Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. South Africa Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoMEA Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Polyclonal Antibodies Market
TABLE 70. List of primary sources, used in the study of global Polyclonal Antibodies Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Polyclonal Antibodies Market, research methodology
FIG 2. Global Polyclonal Antibodies Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Polyclonal Antibodies Market, key trends 2022
FIG 5. Global Polyclonal Antibodies Market, growth prospects 2023-2030
FIG 6. Global Polyclonal Antibodies Market, porters 5 force model
FIG 7. Global Polyclonal Antibodies Market, pest analysis
FIG 8. Global Polyclonal Antibodies Market, value chain analysis
FIG 9. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Polyclonal Antibodies Market, regional snapshot 2020 & 2030
FIG 15. North America Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 16. Europe Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 18. Latin America Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Polyclonal Antibodies Market 2020 & 2030 (USD Million)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
